News
Alphas tour Talecris Prolastin-C plant
The Herald, North Carolina
It’s not every day that patients get to see how their life-changing medications are made. But recently, more than 50 patients from around the nation traveled to Research Triangle Park and Clayton, NC, to witness first-hand the process of transforming human blood plasma into essential treatments for hemophilia, genetic emphysema, immune deficiencies and other life-threatening conditions.
The fifth annual “Up Close and Personal” patient open house provided an opportunity for patients to learn how protein therapies are made and to personally connect with the individuals who make them.
“Being able to see all that is involved in producing this drug in a safe fashion really puts a different perspective on the whole process,” said Gail Tipper, a patient from Wilmington, who attended the events in 2008 and 2009. Tipper receives a Talecris product called Prolastin-C to treat Alpha-1 Antitrypsin Deficiency.
